MoS2/Au–Ag@PEG nanosheets with plasmonic coupling effect-enhanced NIR-II photothermal remedy and silver ion launch for mixed therapy of MRSA an infection

The evolution of bacterial resistance to antibiotics has resulted in a worldwide public well being disaster, necessitating the event of novel antibiotic-independent antimicrobial methods. On this examine, MoS₂/Au–Ag@PEG nanosheets (MAAP NSs) have been ready by way of sequential deposition of gold and silver nanoparticles onto MoS₂ nanosheets (MoS₂ NSs), which have been then used for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) infections. In comparison with MoS₂ NSs, MAAP NSs exhibit a considerably enhanced near-infrared area II (NIR-II) absorption at 1064 nm (a 7.51-fold improve), and the photothermal conversion effectivity improves by 50.7%, reaching 19.9%. Theoretical simulations reveal that the plasmonic coupling impact between adjoining Au–Ag nanoparticles (Au–Ag NPs) on the floor of MAAP NSs results in the formation of sizzling spots and considerably enhances NIR-II mild absorption, thereby bettering the NIR-II photothermal efficiency. Furthermore, the discharge of silver ions (Ag⁺) might be successfully managed by NIR laser irradiation. In vitro experimental outcomes present that, upon NIR-II laser (1064 nm) publicity, MAAP NSs can successfully remove established MRSA biofilms with a bacterial inactivation effectivity of 99.992%. Notably, benefiting from the superior tissue penetration of the NIR-II laser, MAAP NSs exhibit potent therapeutic efficacy in opposition to each superficial wound an infection and subcutaneous implant-associated MRSA biofilm an infection in mouse fashions. In vivo outcomes reveal that, underneath NIR-II laser stimulation, MAAP NSs cannot solely successfully kill 99.95% of MRSA in contaminated wounds and speed up wound therapeutic, but additionally take away MRSA biofilms from subcutaneous implant surfaces, reaching a 99.92% bacterial discount. This work presents a novel technique for designing NIR-II responsive antibacterial nanoagents based mostly on plasmonic coupling results in two-dimensional (2D) nanosheets and offers a promising answer for the therapy of antibiotic-resistant bacterial infections.